Correlation Between Mineralys Therapeutics, and Bavarian Nordic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Bavarian Nordic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Bavarian Nordic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Bavarian Nordic AS, you can compare the effects of market volatilities on Mineralys Therapeutics, and Bavarian Nordic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Bavarian Nordic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Bavarian Nordic.

Diversification Opportunities for Mineralys Therapeutics, and Bavarian Nordic

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between Mineralys and Bavarian is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Bavarian Nordic AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bavarian Nordic AS and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Bavarian Nordic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bavarian Nordic AS has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Bavarian Nordic go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Bavarian Nordic

Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 1.4 times more return on investment than Bavarian Nordic. However, Mineralys Therapeutics, is 1.4 times more volatile than Bavarian Nordic AS. It trades about -0.01 of its potential returns per unit of risk. Bavarian Nordic AS is currently generating about -0.17 per unit of risk. If you would invest  1,350  in Mineralys Therapeutics, Common on September 4, 2024 and sell it today you would lose (63.00) from holding Mineralys Therapeutics, Common or give up 4.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Mineralys Therapeutics, Common  vs.  Bavarian Nordic AS

 Performance 
       Timeline  
Mineralys Therapeutics, 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively abnormal basic indicators, Mineralys Therapeutics, unveiled solid returns over the last few months and may actually be approaching a breakup point.
Bavarian Nordic AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bavarian Nordic AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Mineralys Therapeutics, and Bavarian Nordic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mineralys Therapeutics, and Bavarian Nordic

The main advantage of trading using opposite Mineralys Therapeutics, and Bavarian Nordic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Bavarian Nordic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bavarian Nordic will offset losses from the drop in Bavarian Nordic's long position.
The idea behind Mineralys Therapeutics, Common and Bavarian Nordic AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Global Correlations
Find global opportunities by holding instruments from different markets